Today’s Research Reports on Trending Tickers: Clovis Oncology and CVS Health
NEW YORK, NY / ACCESSWIRE / April 9, 2018 / U.S. equities experienced weekly losses last week as rising concerns over a potential trade war continued to pressure markets lower on Friday. The Dow Jones Industrial Average plunged 2.34 percent to close at 23,932.76, while the S&P 500 Index fell 2.19 percent to close at 2,604.47. The Nasdaq Composite Index declined 2.28 percent to close at 6,915.11.
"Today's market reaction is a reflection of investor fears that the trade rhetoric will get a lot tougher before any negotiations between U.S. and China get going," said Ryan Larson, head of equity trading at RBC Global Asset Management.
RDI Initiates Coverage on:
Clovis Oncology, Inc.
https://rdinvesting.com/news/?ticker=CLVS
CVS Health Corporation
https://rdinvesting.com/news/?ticker=CVS
Clovis Oncology's stock jumped 5.85% Friday, to close the day at $55.52. The stock recorded a trading volume of 3,468,512 shares, which was above its three months average volume of 1,247,149 shares. In the last year, Clovis Oncology's shares have traded in a range of 45.42 - 99.45. The share price has gained 22.24% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $57.11 is below its 200-day moving average of $64.62. Shares of Clovis Oncology have fallen roughly 6.95 percent in the past month and are down 18.35 percent year-to-date.
Access RDI's Clovis Oncology, Inc. Research Report at:
https://rdinvesting.com/news/?ticker=CLVS
On Friday, shares of CVS Health recorded a trading volume of 5,114,814 shares, which was below the three months average volume of 8,659,837 shares. The stock ended the day 1.98% lower at 63.38. The stock is currently trading 24.55% below its 52 week high with a 52 week trading range of 60.14 - 84.00. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $65.71 is below its 200-day moving average of $72.47. Shares of the company are trading at a Price to Earnings ratio of 9.84. Shares of CVS Health have fallen roughly 6.12 percent in the past month and are down 12.58 percent year-to-date.
Access RDI's CVS Health Corporation Research Report at:
https://rdinvesting.com/news/?ticker=CVS
Our Actionable Research on Clovis Oncology, Inc. (NASDAQ :CLVS) and CVS Health Corporation (NYSE :CVS) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE: RDInvesting.com
